Iocarmic acid

{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 407427669 | IUPAC_name = 3-(5-{[3-carboxy-2,4,6-triiodo-5-(methylcarbamoyl)phenyl]carbamoyl}pentanamido)-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid | image = Iocarmic acid.png

| tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =

| CAS_number_Ref =  ^Y | CAS_number = 10397-75-8 | ATC_prefix = V08 | ATC_suffix = AA08 | PubChem = 25229 | DrugBank_Ref =  ^Y | DrugBank = | UNII_Ref =  ^N | UNII = 82PB24K6TZ | KEGG_Ref =  ^Y | KEGG = D01099 | ChemSpiderID_Ref =  ^N | ChemSpiderID = 23564

| C=24 | H=20 | I=6 | N=4 | O=8 | molecular_weight = 1253.86 g/mol | synonyms = 3-[[6-[[3-Carboxy-2,4,6-triiodo-5-(methylcarbamoyl)phenyl]amino]-6-oxohexanoyl]amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid | smiles = CNC(=O)c1c(c(c(c(c1I)NC(=O)CCCCC(=O)Nc2c(c(c(c(c2I)C(=O)O)I)C(=O)NC)I)I)C(=O)O)I | InChI = 1/C24H20I6N4O8/c1-31-21(37)9-13(25)11(23(39)40)17(29)19(15(9)27)33-7(35)5-3-4-6-8(36)34-20-16(28)10(22(38)32-2)14(26)12(18(20)30)24(41)42/h3-6H2,1-2H3,(H,31,37)(H,32,38)(H,33,35)(H,34,36)(H,39,40)(H,41,42) | InChIKey = SMQYOVYWPWASGU-UHFFFAOYAT | StdInChI_Ref =  ^N | StdInChI = 1S/C24H20I6N4O8/c1-31-21(37)9-13(25)11(23(39)40)17(29)19(15(9)27)33-7(35)5-3-4-6-8(36)34-20-16(28)10(22(38)32-2)14(26)12(18(20)30)24(41)42/h3-6H2,1-2H3,(H,31,37)(H,32,38)(H,33,35)(H,34,36)(H,39,40)(H,41,42) | StdInChIKey_Ref =  ^N | StdInChIKey = SMQYOVYWPWASGU-UHFFFAOYSA-N

}}

Iocarmic acid is a molecule used as a contrast medium.